Clinical Trial Update: Melatonin Agonist for Shift-time Workers. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a melatonin receptor agonist for circadian rhythm disorders in shift workers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Circadian Rhythm Sleep Disorder
• Shift Work Sleep Disorder

Drugs mentioned

• Melatonin receptor agonist

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Circadian Rhythm Disorders | Phase 4 | Status: COMPLETED